The impact of harmonization on ELISPOT assay performance

Area of Science:

• Immunological Sciences
• Clinical Immunology
• Assay Development

Background:

• The Enzyme-Linked ImmunoSpot (ELISPOT) assay is a well-established tool in immunological sciences for over 25 years.
• It is widely used for quantifying and functionally characterizing immune cells that secrete various molecules.
• ELISPOT assays have seen increasing implementation in clinical trials for immune monitoring over the past decade.

Purpose of the Study:

• To address challenges arising from the wide disparity of applied ELISPOT protocols in clinical trial settings.
• To discuss the influence of harmonization strategies in overcoming these challenges.
• To explore harmonization in the context of assay standardization and validation.

Main Methods:

• Review of existing ELISPOT assay principles and their adaptations in individual laboratories.
• Analysis of consequences of protocol variations on ELISPOT assay reliability.
• Discussion of harmonization strategies for ELISPOT assays in clinical trials.

Main Results:

• Significant variations in ELISPOT assay protocols exist due to adaptations by individual laboratories.
• These protocol disparities pose challenges for consistent ELISPOT use in clinical trials.
• Harmonization strategies are identified as a key tool for improving assay standardization and validation.

Conclusions:

• Harmonization of ELISPOT assay protocols is essential for reliable immune monitoring in clinical trials.
• Standardization and validation are critical components of successful ELISPOT assay harmonization.
• Addressing protocol variability will enhance the utility of ELISPOT assays in diverse research and clinical applications.